Lipocine (LPCN) Analyst Estimates Annual - Discounting Cash Flows
Lipocine Inc.
LPCN (NASDAQ)

* (except for per share items) of USD
Period Ending: 2028
12-31
2027
12-31
2026
12-31
2025
12-31
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2019
12-31
2018
12-31
Number of Analysts 1 1 1 2 2 1 1 1 1 1
Estimated Revenue
Low 10.3 8.20 2.61 1.90 7.79 -4.44 1.40 2.95 0.16 0.33
Average 18.7 8.20 2.61 3.45 9.06 -3.07 1.81 3.75 0.20 0.42
High 27.1 8.20 2.61 5.00 10.3 -1.69 2.21 4.55 0.24 0.51
Estimated EBITDA
Low -0.14 -0.04 -0.01 -0.03 -0.06 0.01 -0.01 0.12 0.01 0.01
Average -0.10 -0.04 -0.01 -0.02 -0.05 0.02 -0.01 0.15 0.01 0.02
High -0.06 -0.04 -0.01 -0.01 -0.04 0.02 -0.01 0.18 0.01 0.02
Estimated EBIT
Low -0.14 -0.04 -0.01 -0.03 -0.06 0.01 -0.01 0.12 0.01 0.01
Average -0.10 -0.04 -0.01 -0.02 -0.05 0.02 -0.01 0.15 0.01 0.02
High -0.06 -0.04 -0.01 -0.01 -0.04 0.02 -0.01 0.18 0.01 0.02
Estimated Net Income
Low 0.22 -4.59 -9.60 -10.2 -6.30 -25.0 -14.7 -16.8 -57.2 -60.6
Average 0.53 -2.90 -6.06 -6.43 -4.06 -16.4 -11.3 -13.1 -44.8 -47.5
High 0.83 -1.21 -2.52 -2.68 -1.66 -6.56 -8.03 -9.50 -32.4 -34.3
Estimated SGA Expenses
Low 86.0 68.3 21.7 15.8 64.9 -37.0 11.7 24.6 1.31 2.74
Average 156 68.3 21.7 28.7 75.4 -25.6 15.0 31.3 1.67 3.49
High 226 68.3 21.7 41.6 86.0 -14.1 18.4 37.9 2.02 4.23
Estimated EPS
Low 0.042 -0.871 -1.821 -1.932 -1.196 -4.735 -2.783 -3.182 -10.85 -11.50
Average 0.100 -0.550 -1.150 -1.220 -0.755 -2.990 -2.153 -2.493 -8.500 -9.010
High 0.158 -0.229 -0.479 -0.508 -0.314 -1.245 -1.524 -1.802 -6.144 -6.513
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us